Selling And Administration Expenses 更改
AbbVie USD 3.61B 273M 2023-12
Abbott USD 2.69B 10M 2023-12
Amgen USD 1.76B 424M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Baxter International USD 832M 47M 2023-12
Bayer EUR 3.6B 81M 2023-09
Becton, Dickinson and Co. USD 1.21B 75M 2023-12
Biogen USD 608.5M 179.7M 2023-12
Boston Scientific USD 1.38B 137M 2023-12
Bristol-Myers Squibb USD 2.06B 126M 2023-12
CONMED USD 127.33M 10.74M 2023-12
Cooper Companies USD 380.9M 6.7M 2023-12
Dexcom USD 300.7M 16M 2023-12
Edwards Lifesciences USD 480M 40.4M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Globus Medical USD 244.72M 88.51M 2023-12
Hologic USD 260.7M 28.3M 2023-12
Insulet USD 212.8M 32.1M 2023-12
Integra LifeSciences USD 146.52M 1.13M 2023-12
Intuitive Surgical USD 567.1M 115.9M 2023-12
J&J USD 5.81B 410M 2023-12
Merck USD 2.75B 272M 2023-12
Merit Medical Systems USD 95.75M 8.9M 2023-12
Pfizer USD 4.47B 1.27B 2023-12
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Stryker USD 1.8B 125M 2023-12
Tandem Diabetes Care USD 85.75M 6.42M 2023-12
Teva Pharmaceutical Industries USD 844M 66M 2023-09
Vertex Pharmaceuticals USD 263.8M 1.2M 2023-09
Zimmer Biomet Holdings USD 722.3M 50.1M 2023-12
Zoetis USD 565M 40M 2023-12



J&J 销售和管理费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.